JP2009526043A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526043A5 JP2009526043A5 JP2008554186A JP2008554186A JP2009526043A5 JP 2009526043 A5 JP2009526043 A5 JP 2009526043A5 JP 2008554186 A JP2008554186 A JP 2008554186A JP 2008554186 A JP2008554186 A JP 2008554186A JP 2009526043 A5 JP2009526043 A5 JP 2009526043A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- chronic
- signs
- symptoms
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77111906P | 2006-02-07 | 2006-02-07 | |
| PCT/SE2007/000107 WO2007091947A2 (en) | 2006-02-07 | 2007-02-06 | Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009526043A JP2009526043A (ja) | 2009-07-16 |
| JP2009526043A5 true JP2009526043A5 (https=) | 2010-03-11 |
Family
ID=38345567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554186A Pending JP2009526043A (ja) | 2006-02-07 | 2007-02-06 | バニロイド受容体１に関連する状態を治療するための新規のスピロ［イミダゾリジン−４，３’−インドール］−２，２”，５’（ｉｈ）−トリオン |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070185179A1 (https=) |
| EP (1) | EP2013215A4 (https=) |
| JP (1) | JP2009526043A (https=) |
| KR (1) | KR20080094906A (https=) |
| CN (1) | CN101415711A (https=) |
| AR (1) | AR059265A1 (https=) |
| AU (1) | AU2007212786B2 (https=) |
| BR (1) | BRPI0707423A2 (https=) |
| CA (1) | CA2641632A1 (https=) |
| CL (1) | CL2009000523A1 (https=) |
| IL (1) | IL192890A0 (https=) |
| NO (1) | NO20083547L (https=) |
| NZ (1) | NZ571070A (https=) |
| RU (1) | RU2421457C2 (https=) |
| SA (1) | SA07280027B1 (https=) |
| SG (1) | SG169387A1 (https=) |
| TW (1) | TW200801011A (https=) |
| UA (1) | UA93226C2 (https=) |
| UY (1) | UY30132A1 (https=) |
| WO (1) | WO2007091947A2 (https=) |
| ZA (1) | ZA200806407B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2781521A4 (en) | 2011-10-19 | 2015-03-04 | Kowa Co | NEW SPIROINDOLIN COMPOUND AND MEDICAL AGENT THEREFOR |
| TWI586668B (zh) * | 2012-09-06 | 2017-06-11 | 第一三共股份有限公司 | 二螺吡咯啶衍生物之結晶 |
| CN108409746B (zh) * | 2018-05-15 | 2021-08-24 | 中山大学 | 一种含吡咯或吲哚并氮杂环烷结构的手性氧代螺环吲哚类化合物及其消旋体和制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU532110B2 (en) | 1979-11-13 | 1983-09-15 | Ici Ltd. | Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives |
| ZA806623B (en) * | 1979-11-13 | 1981-12-30 | Ici Ltd | Substituted indoline-2-one derivatives |
| IE52879B1 (en) | 1981-05-12 | 1988-03-30 | Ici Plc | Pharmaceutical spiro-hydantoin derivatives |
| GB8331194D0 (en) | 1982-12-20 | 1983-12-29 | Ici Plc | Chemical process |
| US4611062A (en) * | 1984-03-26 | 1986-09-09 | Imperial Chemical Industries Plc | Process for resolving certain spiro compounds |
| WO1992007830A2 (en) | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
| HUP0203548A3 (en) * | 1999-07-21 | 2003-04-28 | Astrazeneca Ab | New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
| US7248802B2 (en) | 2002-11-27 | 2007-07-24 | Nokia Corporation | Distribution of a synchronization signal in an optical communication system |
| TW200508197A (en) | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
| SE0301446D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | New Compounds |
| US7585878B2 (en) | 2003-06-12 | 2009-09-08 | Astellas Pharma Inc. | Benzamide derivative or salt thereof |
| GB0326633D0 (en) * | 2003-11-14 | 2003-12-17 | Merck Sharp & Dohme | Therapeutic agents |
| US7879866B2 (en) | 2004-07-19 | 2011-02-01 | Dorte Xenia Gram | Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders |
| WO2007091948A2 (en) * | 2006-02-07 | 2007-08-16 | Astrazeneca Ab | Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1 |
-
2007
- 2007-01-31 AR ARP070100412A patent/AR059265A1/es not_active Application Discontinuation
- 2007-01-31 TW TW096103591A patent/TW200801011A/zh unknown
- 2007-02-05 US US11/671,153 patent/US20070185179A1/en not_active Abandoned
- 2007-02-06 AU AU2007212786A patent/AU2007212786B2/en not_active Ceased
- 2007-02-06 SG SG201100854-7A patent/SG169387A1/en unknown
- 2007-02-06 KR KR1020087019272A patent/KR20080094906A/ko not_active Withdrawn
- 2007-02-06 SA SA07280027A patent/SA07280027B1/ar unknown
- 2007-02-06 RU RU2008131905/04A patent/RU2421457C2/ru not_active IP Right Cessation
- 2007-02-06 UY UY30132A patent/UY30132A1/es not_active Application Discontinuation
- 2007-02-06 NZ NZ571070A patent/NZ571070A/en unknown
- 2007-02-06 EP EP07709323A patent/EP2013215A4/en not_active Withdrawn
- 2007-02-06 BR BRPI0707423-9A patent/BRPI0707423A2/pt not_active IP Right Cessation
- 2007-02-06 CA CA002641632A patent/CA2641632A1/en not_active Abandoned
- 2007-02-06 JP JP2008554186A patent/JP2009526043A/ja active Pending
- 2007-02-06 CN CNA2007800125819A patent/CN101415711A/zh active Pending
- 2007-02-06 WO PCT/SE2007/000107 patent/WO2007091947A2/en not_active Ceased
- 2007-06-02 UA UAA200809311A patent/UA93226C2/ru unknown
-
2008
- 2008-07-17 IL IL192890A patent/IL192890A0/en unknown
- 2008-07-23 ZA ZA200806407A patent/ZA200806407B/xx unknown
- 2008-08-14 NO NO20083547A patent/NO20083547L/no not_active Application Discontinuation
- 2008-11-20 US US12/274,837 patent/US7868181B2/en not_active Expired - Fee Related
-
2009
- 2009-03-05 CL CL2009000523A patent/CL2009000523A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525444A5 (https=) | ||
| JP2007507065A5 (https=) | ||
| MX2009009492A (es) | Compuestos organicos biciclicos adecuados para el tratamiento de condiciones inflamatorias o alergicas. | |
| JP2009529541A5 (https=) | ||
| WO2007149797A3 (en) | Use of organic compounds | |
| EP2067765A3 (en) | Intermediate compounds and their use in preparation of lacosamide | |
| WO2009042922A3 (en) | Peptide-peptidase inhibitor conjugates and methods of making and using same | |
| TW200738632A (en) | Cannabinoid receptor modulators | |
| NZ602166A (en) | Antibodies to il-6 and use thereof | |
| JP2010513478A5 (https=) | ||
| JP2010526777A5 (https=) | ||
| JP2008501714A5 (https=) | ||
| CL2007001731A1 (es) | Compuestos derivados de imidazo[1,5-a]pirimidina; composicion farmaceutica; y uso para tratar o prevenir un trastorno asociado con el deterioro cognitivo, la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras. | |
| WO2009067493A3 (en) | 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders | |
| JP2011527333A5 (https=) | ||
| WO2008065384A3 (en) | Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor | |
| EP2500337A3 (en) | Solid form comprising (-) o-desmethylvenlafaxine and uses thereof | |
| PE20121349A1 (es) | N-((1r,2s,5r)-5-(tert-butilamino)-2-((s)-3-(7-tert-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oxopirrolidin-1-il)ciclohexil)acetamida, un modulador dual de la actividad del receptor de quimiocinas, formas cristalinas y procesos | |
| JP2009526043A5 (https=) | ||
| EA201100605A1 (ru) | Комбинированная терапия, включающая ингибитор dhodh и метотрексат, для лечения аутоиммунного заболевания | |
| IL186374A (en) | Combined use of prostaglandin compound and ppi for the manufacture of pharmacological compounds for the treatment of gastrointestinal disorders and pharmaceutical compounds containing them | |
| JP2011509306A5 (https=) | ||
| JP2013525490A5 (https=) | ||
| MY146429A (en) | 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e-]-[1,2,4]-triazolo-[1,5-c-]-pyrimidin-5-amine | |
| JP2009519974A5 (https=) |